Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6.

Saini RK, Kaneko I, Jurutka PW, Forster R, Hsieh A, Hsieh JC, Haussler MR, Whitfield GK.

Calcif Tissue Int. 2013 Apr;92(4):339-53. doi: 10.1007/s00223-012-9683-5. Epub 2012 Dec 22.

2.

Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.

Jurutka PW, Bartik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, Hsieh JC, Kaczmarska M, Haussler CA, Haussler MR.

J Bone Miner Res. 2007 Dec;22 Suppl 2:V2-10. doi: 10.1359/jbmr.07s216.

3.

1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.

Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK.

Am J Physiol Gastrointest Liver Physiol. 2005 Dec;289(6):G1036-42. Epub 2005 Jul 14.

4.

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.

J Endocrinol. 1997 Sep;154 Suppl:S57-73. Review.

5.

Vitamin D and type II sodium-dependent phosphate cotransporters.

Kido S, Kaneko I, Tatsumi S, Segawa H, Miyamoto K.

Contrib Nephrol. 2013;180:86-97. doi: 10.1159/000346786. Epub 2013 May 6. Review.

PMID:
23652552
6.

Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.

Raval-Pandya M, Freedman LP, Li H, Christakos S.

Mol Endocrinol. 1998 Sep;12(9):1367-79.

PMID:
9731705
7.

1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.

Barthel TK, Mathern DR, Whitfield GK, Haussler CA, Hopper HA 4th, Hsieh JC, Slater SA, Hsieh G, Kaczmarska M, Jurutka PW, Kolek OI, Ghishan FK, Haussler MR.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):381-8. Epub 2007 Feb 12.

PMID:
17293108
9.

1,25-dihydroxyvitamin D3 down-regulation of PHEX gene expression is mediated by apparent repression of a 110 kDa transfactor that binds to a polyadenine element in the promoter.

Hines ER, Kolek OI, Jones MD, Serey SH, Sirjani NB, Kiela PR, Jurutka PW, Haussler MR, Collins JF, Ghishan FK.

J Biol Chem. 2004 Nov 5;279(45):46406-14. Epub 2004 Aug 25.

10.

Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.

Zella LA, Kim S, Shevde NK, Pike JW.

Mol Endocrinol. 2006 Jun;20(6):1231-47. Epub 2006 Feb 23.

PMID:
16497728
11.

Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.

Christakos S, Raval-Pandya M, Wernyj RP, Yang W.

Biochem J. 1996 Jun 1;316 ( Pt 2):361-71. Review. Erratum in: Biochem J 1996 Sep 15;318(Pt 3):1079.

12.

Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.

Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R.

J Bone Miner Res. 2001 Apr;16(4):625-38.

13.

Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.

Staal A, Birkenhäger JC, Pols HA, Buurman CJ, Vink-van Wijngaarden T, Kleinekoort WM, van den Bemd GJ, van Leeuwen JP.

Bone Miner. 1994 Jul;26(1):27-42.

PMID:
7950503
14.

Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.

Saji F, Shigematsu T, Sakaguchi T, Ohya M, Orita H, Maeda Y, Ooura M, Mima T, Negi S.

Am J Physiol Renal Physiol. 2010 Nov;299(5):F1212-7. doi: 10.1152/ajprenal.00169.2010. Epub 2010 Aug 25.

15.

The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D3.

Lee SM, Pike JW.

J Steroid Biochem Mol Biol. 2016 Nov;164:265-270. doi: 10.1016/j.jsbmb.2015.08.018. Epub 2015 Aug 29.

16.
17.

FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes.

Kaneko I, Saini RK, Griffin KP, Whitfield GK, Haussler MR, Jurutka PW.

J Endocrinol. 2015 Sep;226(3):155-66. doi: 10.1530/JOE-15-0225. Epub 2015 Jul 6.

18.

Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.

Sasaki H, Harada H, Handa Y, Morino H, Suzawa M, Shimpo E, Katsumata T, Masuhiro Y, Matsuda K, Ebihara K, et al.

Biochemistry. 1995 Jan 10;34(1):370-7.

PMID:
7819220
19.

Supplemental Content

Support Center